The effects of cotrimoxazole or tenofovir co-administration on the pharmacokinetics of maraviroc in healthy volunteers.
about
Maraviroc: a review of its use in HIV infection and beyondCYP3A5 genotype impacts maraviroc concentrations in healthy volunteers.Pharmacokinetics of mefloquine and its effect on sulfamethoxazole and trimethoprim steady-state blood levels in intermittent preventive treatment (IPTp) of pregnant HIV-infected women in Kenya.New antiretroviral drugs: a review of the efficacy, safety, pharmacokinetics, and resistance profile of tipranavir, darunavir, etravirine, rilpivirine, maraviroc, and raltegravir.Treatment of HIV infection with the CCR5 antagonist maraviroc.
P2860
The effects of cotrimoxazole or tenofovir co-administration on the pharmacokinetics of maraviroc in healthy volunteers.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
The effects of cotrimoxazole o ...... raviroc in healthy volunteers.
@ast
The effects of cotrimoxazole o ...... raviroc in healthy volunteers.
@en
type
label
The effects of cotrimoxazole o ...... raviroc in healthy volunteers.
@ast
The effects of cotrimoxazole o ...... raviroc in healthy volunteers.
@en
prefLabel
The effects of cotrimoxazole o ...... raviroc in healthy volunteers.
@ast
The effects of cotrimoxazole o ...... raviroc in healthy volunteers.
@en
P2093
P2860
P1476
The effects of cotrimoxazole o ...... raviroc in healthy volunteers.
@en
P2093
Caroline E Ridgway
Deborah Russell
Gary J Muirhead
Lyndsey A Whitlock
Samantha Abel
P2860
P356
10.1111/J.1365-2125.2008.03135.X
P407
P478
65 Suppl 1
P577
2008-04-01T00:00:00Z